Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Authors

Institutions

Publication Details

Journal
Hypertension
Published
2025-12-05
DOI
https://doi.org/10.1161/hypertensionaha.125.25955
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Bruce A. Perkins, Tosin Osuntokun, Josephine Tse, Daan J. Touw et al.
Hypertension
Diabetes Treatment and Management
article

Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Bruce A. Perkins, Tosin Osuntokun, Josephine Tse, Daan J. Touw, Massimo Nardone, Brian Y.H. Lam, Dylan Burger, David Z.I. Cherney, Leif E. Lovblom, Hiddo J.L. Heerspink, Ryan Lam, Hongyan Liu, Vikas S. Sridhar, Tomoyuki Tobushi, Yangqing Deng, Yuliya Lytvyn, Luxcia Kugathasan, Julie A. Lovshin, Jasper Stevens, John S. Floras
article en

Abstract

No abstract available for this paper.
HypertensionVol. 83(2)
Mount Sinai Hospital (CA), Sunnybrook Health Science Centre (CA), University Health Network (CA), University Medical Center Groningen (NL), University of British Columbia (CA), University of Toronto (CA), Lunenfeld-Tanenbaum Research Institute (CA), Ottawa Hospital (CA), Institute of Health Services and Policy Research (CA)
Openalex Percentile: Top 49%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial — Bruce A. Perkins, Tosin Osuntokun, et al. · Hypertension (2025) | TGRS Research Map | TGRS